Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126432613 | 12643261 | 3 | F | 20160913 | 20160811 | 20160922 | EXP | AT-BAXTER-2016BAX041705 | BAXTER | 0.00 | F | Y | 45.00000 | KG | 20160922 | MD | AT | AT |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126432613 | 12643261 | 1 | PS | EXTRANEAL | CALCIUM CHLORIDEICODEXTRINMAGNESIUM CHLORIDESODIUM CHLORIDESODIUM LACTATE | 1 | Intraperitoneal | 1 BAG | D | 0 | 2000 | ML | SOLUTION FOR PERITONEAL DIALYSIS | ||||||
| 126432613 | 12643261 | 2 | SS | PHYSIONEAL 40 GLUCOSE 1,36% W/V/13,6 MG/ML CLEAR-FLEX - PERITONEALDIAL | CALCIUM CHLORIDEDEXTROSE MONOHYDRATEMAGNESIUM CHLORIDESODIUM BICARBONATESODIUM CHLORIDESODIUM LACTATE | 1 | Intraperitoneal | 2 BAGS | D | 0 | 5000 | ML | SOLUTION FOR PERITONEAL DIALYSIS | ||||||
| 126432613 | 12643261 | 3 | SS | PHYSIONEAL 40 GLUCOSE 2,27% W/V/22,7 MG/ML CLEAR-FLEX - PERITONEALDIAL | CALCIUM CHLORIDEDEXTROSE MONOHYDRATEMAGNESIUM CHLORIDESODIUM BICARBONATESODIUM CHLORIDESODIUM LACTATE | 1 | Intraperitoneal | D | 0 | 5000 | ML | SOLUTION FOR PERITONEAL DIALYSIS | |||||||
| 126432613 | 12643261 | 4 | C | T-ASS | 2 | Unknown | 0 | 100 | MG | SOLUTION FOR PERITONEAL DIALYSIS | |||||||||
| 126432613 | 12643261 | 5 | C | Hydal | HYDROMORPHONE HYDROCHLORIDE | 1 | Unknown | 0 | 2 | MG | BID | ||||||||
| 126432613 | 12643261 | 6 | C | CYMBALTA | DULOXETINE HYDROCHLORIDE | 1 | Unknown | 1/2 | 0 | 60 | MG | ||||||||
| 126432613 | 12643261 | 7 | C | Lexotanil | BROMAZEPAM | 1 | Unknown | 1/2 | 0 | 3 | MG | ||||||||
| 126432613 | 12643261 | 8 | C | NOVALGIN | METAMIZOLE SODIUM | 1 | Unknown | 3X20 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126432613 | 12643261 | 1 | Peritoneal dialysis |
| 126432613 | 12643261 | 2 | Peritoneal dialysis |
| 126432613 | 12643261 | 3 | Peritoneal dialysis |
| 126432613 | 12643261 | 4 | Coronary artery disease |
| 126432613 | 12643261 | 5 | Musculoskeletal pain |
| 126432613 | 12643261 | 6 | Depression |
| 126432613 | 12643261 | 7 | Depression |
| 126432613 | 12643261 | 8 | Musculoskeletal pain |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126432613 | 12643261 | OT |
| 126432613 | 12643261 | HO |
| 126432613 | 12643261 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126432613 | 12643261 | Cardiovascular insufficiency | |
| 126432613 | 12643261 | Cerebral arteriosclerosis | |
| 126432613 | 12643261 | Cerebral atrophy | |
| 126432613 | 12643261 | Cerebral haematoma | |
| 126432613 | 12643261 | Cerebral microangiopathy | |
| 126432613 | 12643261 | Enterococcal sepsis | |
| 126432613 | 12643261 | Fall | |
| 126432613 | 12643261 | Laceration | |
| 126432613 | 12643261 | Skin disorder |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126432613 | 12643261 | 1 | 20160805 | 0 | ||
| 126432613 | 12643261 | 2 | 20160805 | 0 | ||
| 126432613 | 12643261 | 3 | 20160805 | 0 | ||
| 126432613 | 12643261 | 4 | 20160805 | 0 |